These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 28031784)

  • 1. Between individualism and social solidarity in vaccination policy: the case of the 2013 OPV campaign in Israel.
    Boas H; Rosenthal A; Davidovitch N
    Isr J Health Policy Res; 2016; 5():64. PubMed ID: 28031784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
    Orenstein WA;
    Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Would it be legally justified to impose vaccination in Israel? Examining the issue in light of the 2013 detection of polio in Israeli sewage.
    Kamin-Friedman S
    Isr J Health Policy Res; 2017 Oct; 6(1):58. PubMed ID: 29084599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination uptake and income inequalities within a mass vaccination campaign.
    Tur-Sinai A; Gur-Arie R; Davidovitch N; Kopel E; Glazer Y; Anis E; Grotto I
    Isr J Health Policy Res; 2019 Jul; 8(1):63. PubMed ID: 31307532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polio Eradication by the year 2000.
    Tukei PM
    Afr J Health Sci; 1996 Aug; 3(3):65. PubMed ID: 17451302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economics of polio vaccination in the post-eradication era: should OPV-using countries adopt IPV?
    Khan MM
    Vaccine; 2008 Apr; 26(16):2034-40. PubMed ID: 18339460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strengths and weaknesses of current polio vaccines--a view from industry.
    André FE
    Dev Biol (Basel); 2001; 105():61-6. PubMed ID: 11763338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges to health workers and their opinions about parents' refusal of oral polio vaccination in the Khyber Pakhtoon Khawa (KPK) province, Pakistan.
    Khan TM; Sahibzada MU
    Vaccine; 2016 Apr; 34(18):2074-81. PubMed ID: 26993330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social media as a platform for health-related public debates and discussions: the Polio vaccine on Facebook.
    Orr D; Baram-Tsabari A; Landsman K
    Isr J Health Policy Res; 2016; 5():34. PubMed ID: 27843544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful control of poliomyelitis by a combined OPV/IPV polio vaccine program in the West Bank and Gaza, 1978-93.
    Tulchinsky T; Abed Y; Handsher R; Toubassi N; Acker C; Melnick J
    Isr J Med Sci; 1994; 30(5-6):489-94. PubMed ID: 8034509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The challenge of changing the inactivated poliomyelitis vaccine in Latin America: declaration of the Latin American Society of Pediatric Infectious Diseases (SLIPE).
    Falleiros-Arlant LH; Avila-Agüero ML; Brea del Castillo J; Mariño C
    Rev Chilena Infectol; 2014 Oct; 31(5):590-603. PubMed ID: 25491459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coverage estimates and patterns of inactivated poliovirus vaccine (IPV) use prior to and during the polio eradication endgame, Jinan City, China, 2010-2015.
    Chang C; Zhang J; Zhou J; Cao R; Song K; Liu C; Zhang X; Geng X; Liu X; Li C
    Hum Vaccin Immunother; 2016 Nov; 12(11):2749-2752. PubMed ID: 27437792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intense campaign for vaccination with the oral polio vaccine: what are the repercussions on the enterovirus world?].
    Delpeyroux F; Guillot S; Szendröi A; Balanant J; Caro V; Cuervo N; Chevaliez S; Dahourou G; Crainic R
    Bull Soc Pathol Exot; 2000 Jul; 93(3):193-7. PubMed ID: 11030056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The golden jubilee of vaccination against poliomyelitis.
    John TJ
    Indian J Med Res; 2004 Jan; 119(1):1-17. PubMed ID: 14997988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.
    Li R; Li CG; Li Y; Liu Y; Zhao H; Chen X; Kuriyakose S; Van Der Meeren O; Hardt K; Hezareh M; Roy-Ghanta S
    Vaccine; 2016 Mar; 34(12):1436-43. PubMed ID: 26873055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivated polio vaccine: time to introduce it in India's national immunization schedule.
    Verma R; Khanna P; Chawla S
    Hum Vaccin Immunother; 2012 Jul; 8(7):956-8. PubMed ID: 22699444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of house-to-house versus fixed-site oral poliovirus vaccine delivery strategies in a mass immunization campaign in Egypt.
    Linkins RW; Mansour E; Wassif O; Hassan MH; Patriarca PA
    Bull World Health Organ; 1995; 73(5):589-95. PubMed ID: 8846484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polio vaccination: past, present and future.
    Bandyopadhyay AS; Garon J; Seib K; Orenstein WA
    Future Microbiol; 2015; 10(5):791-808. PubMed ID: 25824845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.